Stocks · News reference

8-K filing — Jasper Therapeutics, Inc. (JSPR)

Oct 15, 2026, 12:00 PMSEC EDGAR

Filed: 2026-10-15 AccNo: 0001213900-26-109587 Size: 244 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

More stocks news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: edgar
Observed: Oct 15, 2026, 12:00 PM
Checked: Oct 15, 2026, 12:00 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaOct 15, 2026, 12:01 PMBenzinga Newsdesk
Jasper Therapeutics Announces Completion Of 18-Patient Enrollment In Phase 2 IgA Nephropathy Cohort Of Vensobafusp Alfa; Initial Data Expected By Year-End
JSPR
BenzingaOct 14, 2026, 6:51 PMBenzinga Newsdesk
William Blair Reinstates Outperform on Jasper Therapeutics
William Blair analyst Matt Phipps reinstates Jasper Therapeutics (NASDAQ:JSPR) with a Outperform.
JSPR
BenzingaOct 7, 2026, 12:01 PMBenzinga Newsdesk
Jasper Therapeutics Announces $0.324/Warrant Cash Tender Offer For All 12,345,707 Outstanding Warrants, Expiring November 6
JSPR